. 2020 Nov 24;10(1):164–172. doi: 10.1002/cam4.3587

Table 4.

Systolic blood pressure before and after bevacizumab treatment in non‐proton pump inhibitors (PPI) and PPI groups.

	mean systolic blood pressure (SD)
	before treatment with bevasizumab [mmHg]	after treatment with bevasizumab [mmHg]	p‐ value
Non‐PPI group	130 (15.33)	143 (19.55)	0.979 ^a
PPI group	120 (5.39)	134 (4.56)	0.979 ^a

^{^a}

Mann‐Whitney U test.